• Je něco špatně v tomto záznamu ?

Local control after tailored surgical treatment of early cervical cancer

D. Cibula, I. Pinkavova, L. Dusek, J. Slama, M. Zikan, D. Fischerova, P. Freitag, P. Dundr

. 2011 ; 21 (4) : 690-8.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu hodnotící studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc12028411

BACKGROUND: It was the aim of our study to analyze oncological outcome and prognostic parameters in patients with early stages cervical cancer after tailored and well-standardized surgical treatment with an adequate follow-up. METHODS: Oncological outcome and prognostic parameters were evaluated in a group of 192 patients with cervical cancer stages IA2 to 2B who had undergone radical hysterectomy (n = 171), radical parametrectomy (n = 12), or radical trachelectomy (n = 9). Procedures were classified as type B (n = 72), type C1 nerve sparing (n = 103), or type C2 (n = 17). RESULTS: Event-free and overall 5-year survivals probabilities reached 92.7% (confidence interval, 89.5%-95.9 %) and 94.1% (confidence interval, 90.9%-97.3 %). There was only 1 isolated pelvic recurrence found of the total of 10 recurrences. Adjuvant radiotherapy was given to only 22% of patients. The most significant independent prognostic parameters in stage IB tumors were lymph node status, histological type, and tumor volume, whereas in stage II, the parameters included histological type and tumor volume, the latter being inversely related to the prognosis. CONCLUSIONS: We have shown an excellent prognosis, especially local control, after tailored surgical treatment of stages IA2 to IIB of cervical cancer, with low prevalence of adjuvant treatment. Different prognostic parameters were observed for stages IB1/IB2 and IIA/B.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028411
003      
CZ-PrNML
005      
20130401003645.0
007      
ta
008      
120817s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1097/igc.0b013e318213653d $2 doi
035    __
$a (PubMed)21412166
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cibula, David, $d 1968- $7 jo20000074072 $u Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. david.cibula@iol.cz
245    10
$a Local control after tailored surgical treatment of early cervical cancer / $c D. Cibula, I. Pinkavova, L. Dusek, J. Slama, M. Zikan, D. Fischerova, P. Freitag, P. Dundr
520    9_
$a BACKGROUND: It was the aim of our study to analyze oncological outcome and prognostic parameters in patients with early stages cervical cancer after tailored and well-standardized surgical treatment with an adequate follow-up. METHODS: Oncological outcome and prognostic parameters were evaluated in a group of 192 patients with cervical cancer stages IA2 to 2B who had undergone radical hysterectomy (n = 171), radical parametrectomy (n = 12), or radical trachelectomy (n = 9). Procedures were classified as type B (n = 72), type C1 nerve sparing (n = 103), or type C2 (n = 17). RESULTS: Event-free and overall 5-year survivals probabilities reached 92.7% (confidence interval, 89.5%-95.9 %) and 94.1% (confidence interval, 90.9%-97.3 %). There was only 1 isolated pelvic recurrence found of the total of 10 recurrences. Adjuvant radiotherapy was given to only 22% of patients. The most significant independent prognostic parameters in stage IB tumors were lymph node status, histological type, and tumor volume, whereas in stage II, the parameters included histological type and tumor volume, the latter being inversely related to the prognosis. CONCLUSIONS: We have shown an excellent prognosis, especially local control, after tailored surgical treatment of stages IA2 to IIB of cervical cancer, with low prevalence of adjuvant treatment. Different prognostic parameters were observed for stages IB1/IB2 and IIA/B.
650    _2
$a adenokarcinom $x farmakoterapie $x mortalita $x radioterapie $x chirurgie $7 D000230
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a spinocelulární karcinom $x farmakoterapie $x mortalita $x radioterapie $x chirurgie $7 D002294
650    _2
$a adjuvantní chemoterapie $x statistika a číselné údaje $7 D017024
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hysterektomie $x metody $7 D007044
650    _2
$a lidé středního věku $7 D008875
650    _2
$a lokální recidiva nádoru $x epidemiologie $x mortalita $x prevence a kontrola $7 D009364
650    _2
$a adjuvantní radioterapie $x statistika a číselné údaje $7 D018714
650    _2
$a konformní radioterapie $7 D020266
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a analýza přežití $7 D016019
650    _2
$a nádory děložního čípku $x farmakoterapie $x mortalita $x radioterapie $x chirurgie $7 D002583
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pinkavová, Ivana, $7 xx0103207 $d 1976-
700    1_
$a Dusek, Ladislav
700    1_
$a Slama, Jiri
700    1_
$a Zikán, Michal, $d 1976- $7 xx0096708
700    1_
$a Fischerova, Daniela
700    1_
$a Freitag, Pavel, $d 1951- $7 xx0018148
700    1_
$a Dundr, Pavel $7 xx0080436
773    0_
$w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 21, č. 4 (2011), s. 690-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21412166 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130401003919 $b ABA008
999    __
$a ok $b bmc $g 950453 $s 785757
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 21 $c 4 $d 690-8 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20120817/11/04

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...